Nivalis Therapeutics, Inc.'s See Remarks was just granted 65,000 options

Stanford L Peng, Nivalis Therapeutics, Inc.'s See Remarks, just received 65,000 options from the company. The strike price of the options received was $11.31, and these expire on January 01, 2028. Peng now owns at least 65,000 options on the company.

Some additional info was provided as follows:

The exercise price is equal to the closing price per share of Common Stock as reported on the Nasdaq Global Market on the date of grant. 1/4th of the shares subject to the option become vested and exercisable on January 2, 2019 and 1/36th of the remaining shares subject to the option shall vest monthly thereafter.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Nivalis Therapeutics, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Securities to be offered to employees in employee benefit plans - June 21, 2018
Departure of Directors or Certain - June 14, 2018
Nivalis Therapeutics, Inc. just filed a prospectus, suggesting it plans to soon issue some securities - June 11, 2018
Entry into a Material Definitive - June 11, 2018

Auto Refresh

Feedback